Dr. Zhigang Yang , DO
General Practice • Flushing, NY
133-29 41rd, Suite 1a
Flushing, NY 11355
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on November 8, 2011; this date does not establish years in practice.
-
Published CMS data list 264 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99213 — Established patient outpatient office visit: 122 service units.
- 99214 — Established patient outpatient office visit: 47 service units.
- 36415 — Insertion of needle into vein for collection of blood sample: 29 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 7 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 15,857 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 1,081 prescription fills, including refills.
- Vascepa (Icosapent Ethyl) — 949 prescription fills, including refills.
- Alendronate Sodium — 791 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 167 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 60% of clinicians listed under General Practice in New York (2024, 121 clinicians with data). Median for this group: 480. Middle half: 159 to 1,406.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,278 in 2020 to 264 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
133-29 41rd
Suite 1a
Flushing, NY 11355
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
New York College Of Osteo Medicine Of New York Institute Of Technology
2010
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
44 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $23,103 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $15,516 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
19,202 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,198,441 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,781.98 across 56 records.
By nature of payment
- Food and Beverage: $1,781.98 across 56 records.
Reporting-company totals (3 largest of 12)
- Amgen Inc.: $324.61 across 12 records.
- Salix Pharmaceuticals, a division of Bausch Health US, LLC: $324.05 across 13 records.
- AstraZeneca Pharmaceuticals LP: $269.32 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
16 years (graduated 2010)
CMS Doctors and Clinicians data list 2010 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2011
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
May accept Medicare assignment
CMS data show this clinician may accept Medicare assignment. Clinicians who do not always accept assignment can decide case by case.
Ask the office before your visit. If a clinician does not accept assignment for a service, they can charge up to 15% more than the Medicare-approved amount, and you may be asked to pay the full amount at the visit.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Yang has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Yang as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Flushing and New York
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 60% of clinicians listed under General Practice in New York (2024, 121 clinicians with data). Median for this group: 480. Middle half: 159 to 1,406.
Too few clinicians listed under General Practice in Flushing have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A lower Medicare-allowed amount than 65% of clinicians listed under General Practice in New York (2024, 121 clinicians with data). Median for this group: $48,626. Middle half: $15,080 to $117,576.
Too few clinicians listed under General Practice in Flushing have Medicare Part B data for 2024 to compare.
Paid by Medicare
A lower Medicare payment amount than 65% of clinicians listed under General Practice in New York (2024, 121 clinicians with data). Median for this group: $37,563. Middle half: $10,608 to $93,619.
Too few clinicians listed under General Practice in Flushing have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under General Practice in New York (2024, 186 clinicians with data). Median for this group: 462. Middle half: 50 to 2,510.
Too few clinicians listed under General Practice in Flushing have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under General Practice in New York (2024, 186 clinicians with data). Median for this group: $29,331. Middle half: $1,020 to $209,203.
Too few clinicians listed under General Practice in Flushing have Medicare Part D data for 2024 to compare.
11 active clinicians are listed under General Practice with a practice address in Flushing, NY (682 in New York).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Flushing
0% of these 11 clinicians have the CMS telehealth indicator.
9.1% of these 11 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 79% from 1,278 in 2020 to 264 in 2024.
- 2020: 1,278
- 2021: 379
- 2022: 367
- 2023: 203
- 2024: 264
-
Medicare-allowed amount
Medicare-allowed amount decreased 72% from $82,768 in 2020 to $23,103 in 2024.
- 2020: $82,768
- 2021: $29,739
- 2022: $31,885
- 2023: $19,299
- 2024: $23,103
-
Paid by Medicare
Paid by Medicare decreased 75% from $62,960 in 2020 to $15,516 in 2024.
- 2020: $62,960
- 2021: $21,458
- 2022: $23,858
- 2023: $14,330
- 2024: $15,516
-
Medicare Part D prescriptions
Medicare Part D prescriptions varied from year to year: 15,161 in 2020 and 15,857 in 2024.
- 2020: 15,161
- 2021: 20,341
- 2022: 11,132
- 2023: 10,029
- 2024: 15,857
-
30-day fills
30-day fills varied from year to year: 19,482 in 2020 and 19,202 in 2024.
- 2020: 19,482
- 2021: 24,075
- 2022: 13,382
- 2023: 12,231
- 2024: 19,202
-
Part D drug cost
Part D drug cost varied from year to year: $2,218,980 in 2020 and $2,198,441 in 2024.
- 2020: $2,218,980
- 2021: $3,113,832
- 2022: $1,908,997
- 2023: $1,594,877
- 2024: $2,198,441
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 21% from $1,474.46 in 2021 to $1,781.98 in 2025.
- 2021: $1,474.46
- 2022: $610.46
- 2023: $1,221.05
- 2024: $1,790.14
- 2025: $1,781.98
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 56 records totaling $1,781.98.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| SPR Therapeutics, Inc |
Food and Beverage
Cash or cash equivalent
|
SPRINT PNS System | General | $180.17 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $125.00 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Vemlidy | General | $125.00 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC |
Food and Beverage
In-kind items and services
|
XIFAXAN | General | $124.20 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
Otezla | General | $122.22 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $104.39 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $31.32 |
| Aimmune Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
VOWST | General | $30.12 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $28.74 |
| Aimmune Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
ZENPEP | General | $28.30 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LINZESS | General | $28.16 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LINZESS | General | $28.13 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $27.68 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
SHINGRIX | General | $26.83 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $25.00 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $24.89 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
CREON | General | $24.86 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $23.25 |
| Esperion Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
NEXLETOL | General | $22.73 |
| Kowa Pharmaceuticals America, Inc. |
Food and Beverage
In-kind items and services
|
ZORYVE | General | $22.73 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $22.72 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $22.26 |
| Esperion Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
NEXLETOL | General | $21.60 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $21.13 |
| Esperion Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
NEXLETOL | General | $20.83 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
122 | 33 | $200.00 | $98.64 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
47 | 24 | $277.45 | $138.88 |
|
36415
Insertion of needle into vein for collection of blood sample
|
29 | 20 | $50.00 | $8.65 |
|
98929
Osteopathic manipulative treatment, 9-10 body regions
|
23 | 15 | $150.00 | $90.04 |
|
99497
Advance care planning, first 30 minutes
|
17 | 17 | $150.50 | $87.68 |
|
G0008
Administration of influenza virus vaccine
|
15 | 15 | $50.00 | $37.09 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
11 | 11 | $30.00 | $15.72 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1,081 | 41,159 | $5,497.48 | 235 |
| Vascepa | Icosapent Ethyl | 949 | 37,485 | $423,567.90 | 225 |
| Alendronate Sodium | Alendronate Sodium | 791 | 29,888 | $3,833.11 | 197 |
| Amlodipine Besylate | Amlodipine Besylate | 711 | 26,325 | $2,950.41 | 148 |
| Donepezil Hcl | Donepezil Hcl | 648 | 24,240 | $3,740.87 | 160 |
| Losartan Potassium | Losartan Potassium | 628 | 24,150 | $3,271.34 | 130 |
| Diclofenac Epolamine | Diclofenac Epolamine | 450 | 16,080 | $256,018.06 | 125 |
| Simvastatin | Simvastatin | 426 | 15,840 | $1,945.73 | 88 |
| Tamsulosin Hcl | Tamsulosin Hcl | 397 | 14,580 | $2,664.47 | 94 |
| Gabapentin | Gabapentin | 386 | 10,460 | $2,181.04 | 139 |
| Metformin Hcl | Metformin Hcl | 303 | 10,485 | $5,735.50 | 69 |
| Metoprolol Succinate | Metoprolol Succinate | 280 | 10,140 | $1,971.04 | 60 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 223 | 6,840 | $2,826.95 | 78 |
| Diclofenac Sodium | Diclofenac Sodium | 220 | 6,782 | $108,239.54 | 103 |
| Linzess | Linaclotide | 215 | 6,630 | $116,911.27 | 69 |
| Omeprazole | Omeprazole | 214 | 6,674 | $1,601.81 | 85 |
| Meclizine Hcl | Meclizine Hcl | 208 | 2,811 | $1,194.15 | 106 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 197 | 226 | $55,898.30 | 195 |
| Finasteride | Finasteride | 191 | 6,450 | $938.67 | 41 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 183 | 6,800 | $140.51 | 70 |
| Metformin Hcl Er | Metformin Hcl | 175 | 7,200 | $673.22 | 50 |
| Montelukast Sodium | Montelukast Sodium | 163 | 5,550 | $931.39 | 44 |
| Lisinopril | Lisinopril | 158 | 5,804 | $622.56 | 28 |
| Levothyroxine Sodium | Levothyroxine Sodium | 155 | 6,233 | $948.18 | 27 |
| Clobetasol Propionate | Clobetasol Propionate | 153 | 4,982 | $24,523.11 | 62 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - GENERAL PRACTICE
I20120118000248
NY
2163699083
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History
NPI enumerated November 08, 2011.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other General Practices in Flushing
- Dr. Uchechukwuka Osadebe, MD
- Dr. Ebere Uzoeto, MD
- Ainanshe Jama
- Dr. Nakia Sarad, DO
- Dr. Louis Peralte, MD
- Dr. Uriel Avezbadalov, MD
Mailing Address
9914 59th Ave, Apt 2g
Corona, NY 113683866
Phone: 9174038795